Headlines about Mannatech (NASDAQ:MTEX) have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Mannatech earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news articles about the company an impact score of 46.9571884444726 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Mannatech (NASDAQ MTEX) traded down $0.15 during trading hours on Monday, hitting $14.10. The company had a trading volume of 2,400 shares, compared to its average volume of 4,269. The company has a quick ratio of 1.33, a current ratio of 1.63 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $38.23, a P/E ratio of 70.50 and a beta of 1.20. Mannatech has a 12 month low of $12.51 and a 12 month high of $22.30.
Mannatech (NASDAQ:MTEX) last issued its quarterly earnings results on Tuesday, November 7th. The company reported $0.50 earnings per share for the quarter. Mannatech had a return on equity of 2.05% and a net margin of 0.48%. The firm had revenue of $42.00 million for the quarter.
Mannatech, Incorporated is a wellness solution provider. The Company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products. The Company operates through the segment of sale of nutritional supplements, skin care and anti-aging products, and weight management and fitness products through network marketing distribution channels in approximately 20 countries.
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.